Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Cadrenal Therapeutics, Inc. is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. The Company's lead program, CAD-1005, is Phase III ready, being researched as a first-in-class 12-lipoxygenase (12-LOX) inhibitor for treating heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. Second-generation 12-LOX oral therapeutics are also in development for chronic indications. Its pipeline includes tecarfarin, a late-stage Phase III ready oral vitamin K antagonist designed to prevent heart attacks, strokes, and deaths from blood clots in patients requiring chronic anticoagulation, including those with end-stage kidney disease (ESKD) and those with left ventricular assist devices (LVADs), and frunexian, a parenteral Factor XIa inhibitor intended for use in acute hospital settings. The development of tecarfarin is focused on ESKD patients with atrial fibrillation and patients with implanted LVADs.
Find out what a historical investment in Cadrenal Therapeutics Inc would be worth today using our CVKD stock calculator.
Buying CVKD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Cadrenal Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CVKD
What is the ticker symbol of Cadrenal Therapeutics Inc?
The ticker symbol for Cadrenal Therapeutics Inc is CVKD.
How much is one share of CVKD?
One share of CVKD is valued at $1.69 as of 20 November 2026.
What is the market capitalisation of Cadrenal Therapeutics Inc CVKD?
As of 20 November 2026 Cadrenal Therapeutics Inc has a market cap of $7.09M.
What is the 52-week high for Cadrenal Therapeutics Inc stock?
The Cadrenal Therapeutics Inc 52-week high stock price is $12.50.
What is the 52-week low for Cadrenal Therapeutics Inc stock?
The Cadrenal Therapeutics Inc 52-week low stock price is $0.82.
Can I buy CVKD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CVKD shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CVKD on Stake
Buy CVKD from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of CVKD from only US$10 with fractional shares